Renalytix (LSE:RENX) Long-Term Debt : £3.85 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Renalytix Long-Term Debt?

Renalytix's Long-Term Debt for the quarter that ended in Mar. 2024 was £3.85 Mil.

Renalytix's quarterly Long-Term Debt declined from Sep. 2023 (£4.73 Mil) to Dec. 2023 (£4.20 Mil) and declined from Dec. 2023 (£4.20 Mil) to Mar. 2024 (£3.85 Mil).

Renalytix's annual Long-Term Debt increased from Jun. 2021 (£0.00 Mil) to Jun. 2022 (£6.24 Mil) but then declined from Jun. 2022 (£6.24 Mil) to Jun. 2023 (£5.93 Mil).

Renalytix Long-Term Debt Historical Data

The historical data trend for Renalytix's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Long-Term Debt Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Debt

Get a 7-Day Free Trial

0.11

6.24

5.93

Renalytix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															5.73	5.93	4.73	4.20	3.85

Renalytix (LSE:RENX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Renalytix Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Renalytix's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (LSE:RENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

RNLX:USA RTNXF:USA 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012